Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the "Debentures"). The Company used cash on hand to ...

Bionano Genomics (NASDAQ:BNGO) will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bionano ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics (BNGO) and BioLife Solutions (BLFS) with bullish sentiments. According to TipRanks.com, ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping (OGM) detected genomic abnormalities in 97.8% of ...

Bionano Genomics Inc (NASDAQ:BNGO) is set to release its Q1 2026 earnings on May 13, 2026. The consensus estimate for Q1 2026 revenue is $6.57 million, and the earnings are expected to come in at ...

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and ...

Bionano Genomics (NASDAQ:BNGO) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Image source: The Motley Fool. Management attributed revenue softness to supply constraints in consumables, not demand weakness, and indicated expected recovery as manufacturing delays are resolved.

In this era of personalized medicine, individualized gene mapping is key – which is why San Diego startup BioNano Genomics’ Irys System just attracted a robust infusion of cash. The company just ...

Bionano Genomics, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.75. Operator: Good day, and welcome to the Bionano’s Third Quarter 2023 Earnings Conference Call.